Implanet Teams With TFS International for Clinical Trial

Bordeaux, France-based orthopedic implant company Implanet S.A. has begun a prospective and multicenter clinical study, designed to document the outcomes of the Jazz Band, a temporary spine implant, in adult degenerative and adult deformity indications.

The Jazz system is intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures.

Implanet has partnered with TFS International, a professional contract research organization based in Sweden, to help ensure a scientifically robust study design and execution.

“We are pleased to announce this important first step in the establishment of our prospective multicenter U.S. study, partnering with a highly reputable CRO to initiate and manage the project with the highest standards of quality and rigor,” said Ludovic Lastennet, CEO of Implanet. “The Jazz Band has tremendous potential as a tool for surgeons to augment spinal fusion in complex adult surgery. As the global leader in Band based technologies, we are excited to take a leadership position in both rapidly expanding our product portfolio and documenting clinical and economic outcomes.”

In addition to the partnership with TFS International, Implanet is finalizing agreements with eminent US spine centers with strong expertise in complex adult degenerative surgery and a deep interest in developing innovative spinal implant technology platforms.

“We are very pleased with Implanet’s decision to partner with TFS on this multicenter U.S. study,” said Daniel Spasic, CEO of TFS International. “TFS will now, together with some of the most renowned medical centers in the country, work diligently to ensure the execution of a successful study and help to position Implanet as an innovator in complex spine surgeries.”